Neokay (Phytomenadione)

Phytomenadione, the active ingredient in Neokay, is a Vitamin K presented as an oral dosage form for oral use. It treats vitamin K deficiency and helps prevent bleeding associated with anticoagulant therapy in patients requiring hemostasis support.

GNH USA supplies Neokay as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Neokay is used to correct deficiencies in the vitamin K‑dependent coagulation pathway and to manage bleeding risks linked to anticoagulant treatment. - Vitamin K deficiency: restores normal clotting factor activity and reduces bleeding tendency. - Anticoagulant‑associated bleeding: counteracts excess anticoagulation and helps achieve hemostasis. - Peri‑operative management: provides rapid vitamin K repletion before surgery in patients on long‑term anticoagulants.

Neokay may be associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional emesis after oral intake. - Diarrhea: loose stools that resolve without intervention. - Abdominal discomfort: cramping or pain in the upper abdomen. - Headache: transient mild headache. - Skin rash: mild erythematous eruption.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical care. - Severe hypersensitivity: angioedema or bronchospasm. - Thrombosis: unexpected clot formation in veins or arteries. - Hemolysis: breakdown of red blood cells in susceptible individuals. - Liver dysfunction: elevated transaminases indicating hepatic stress. - Coagulopathy reversal failure: inadequate response leading to persistent bleeding.

Before prescribing Neokay, clinicians should consider several safety measures. - Assess vitamin K status: evaluate baseline coagulation parameters and dietary intake. - Monitor anticoagulant therapy: adjust doses of warfarin or other agents as needed. - Caution in liver disease: impaired synthesis of clotting factors may alter response. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Use with newborns cautiously: neonatal dosing requires specialist guidance. - Store at ambient temperature: keep in original container, protect from moisture and light.

Neokay can interact with several medications that affect coagulation or vitamin K metabolism.

Major Interactions (Avoid): - Warfarin: concurrent use may blunt anticoagulant effect and require dose adjustment. - Direct oral anticoagulants (DOACs): may reduce therapeutic anticoagulation. - Broad‑spectrum antibiotics: disrupt gut flora that synthesize vitamin K, altering response.

Moderate Interactions (Monitor Closely): - Lipid‑lowering agents (statins): may modestly affect vitamin K metabolism. - Corticosteroids: can influence coagulation factor levels. - Diuretics: may change plasma concentration of vitamin K.